EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 6th, 2006 • Fermavir Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This EXECUTIVE EMPLOYMENT AGREEMENT (the "Agreement") dated effective as of March 28, 2006 (the "Effective Date") is made and entered into by and between Frederick Larcombe, an individual (the "Executive") FermaVir Pharmaceuticals, Inc., a company incorporated under the laws of the state of Florida (the "Company").
TECHNOLOGY ACQUISITION AGREEMENTTechnology Acquisition Agreement • April 6th, 2006 • Fermavir Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
ThisTECHNOLOGY ACQUISITION AGREEMENT(the “Agreement”) is dated effective as of March 16, 2006 (the “Effective Date”) by and among FermaVir Pharmaceuticals, Inc., a Florida corporation (“Fermavir”) and Fermavir Research, Inc., a Delaware corporation (“Fermavir Research”, and together with Fermavir referred herein as the “Company”), on the one hand, and Chris McGuigan, a resident of Wales, Erik DeClercq, a resident of Belgium and Jan Balzarini, a resident of Belgium (collectively, “Holders”), on the other hand, with reference to the facts and circumstances set forth in the Recitals below.
FERMAVIR PHARMACEUTICALS, INC. REPURCHASE OPTION AGREEMENTRepurchase Option Agreement • April 6th, 2006 • Fermavir Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT is made as of March 16, 2006 between FermaVir Pharmaceuticals, Inc., a Florida corporation (the “Company”), and Chris McGuigan (the “Shareholder”).
